Lapitan, Bernadine .
HRN: 28-17-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2025
CEFUROXIME 1.5GM (VIAL)
12/11/2025
12/18/2025
IV
1.5g
Q8h
STAT CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes